NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
9.20
+0.31 (3.49%)
At close: Oct 24, 2025, 4:00 PM EDT
9.22
+0.02 (0.22%)
After-hours: Oct 24, 2025, 6:01 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $24.62 million as of October 24, 2025. Its market cap has decreased by -36.23% in one year.
Market Cap
24.62M
Enterprise Value
-5.10M
1-Year Change
-36.23%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $24.62M, a decrease of -94.36%. That is a compound annual growth rate of -35.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 23.79M | 10.18% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |